{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:59:11Z","timestamp":1790776751188,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM152121"],"award-info":[{"award-number":["R35GM152121"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000076","name":"National Science Foundation Directorate for Biological Sciences","doi-asserted-by":"publisher","award":["MCA06N060"],"award-info":[{"award-number":["MCA06N060"]}],"id":[{"id":"10.13039\/100000076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011769","name":"Scripps Research","doi-asserted-by":"publisher","award":["CYP2D6"],"award-info":[{"award-number":["CYP2D6"]}],"id":[{"id":"10.13039\/100011769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000181","name":"Air Force Office of Scientific Research","doi-asserted-by":"publisher","award":["AWD005464"],"award-info":[{"award-number":["AWD005464"]}],"id":[{"id":"10.13039\/100000181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000181","name":"Air Force Office of Scientific Research","doi-asserted-by":"publisher","award":["R24-GM145965"],"award-info":[{"award-number":["R24-GM145965"]}],"id":[{"id":"10.13039\/100000181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005471","name":"Beckman Institute for Advanced Science and Technology, University of Illinois, Urbana-Champaign","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000997","name":"Arnold and Mabel Beckman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005413","name":"Universit\u00e9 Paris Descartes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.molpha.2026.100114","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:51:18Z","timestamp":1771951878000},"page":"100114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elucidating the binding and metabolic interactions of sunitinib and sorafenib with Cytochrome P450s CYP2U1 and CYP2D6"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8240-8567","authenticated-orcid":false,"given":"Tiffany Y.-C.","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4057-532X","authenticated-orcid":false,"given":"Yupeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2354-7286","authenticated-orcid":false,"given":"Peter","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8434-1010","authenticated-orcid":false,"given":"Emad","family":"Tajkhorshid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.molpha.2026.100114_bib1","first-page":"263","article-title":"Basic review of the cytochrome p450 system","volume":"4","author":"McDonnell","year":"2013","journal-title":"J Adv Pract Oncol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100114_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s43188-020-00056-z","article-title":"A history of the roles of cytochrome P450 enzymes in the toxicity of drugs","volume":"37","author":"Guengerich","year":"2021","journal-title":"Toxicol Res"},{"key":"10.1016\/j.molpha.2026.100114_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107601","article-title":"CYP2J2 molecular recognition: a new axis for therapeutic design","volume":"215","author":"Das","year":"2020","journal-title":"Pharmacol Ther"},{"issue":"51","key":"10.1016\/j.molpha.2026.100114_bib4","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1021\/acs.biochem.7b01025","article-title":"Arachidonic acid metabolism by human cardiovascular CYP2J2 is modulated by doxorubicin","volume":"56","author":"Arnold","year":"2017","journal-title":"Biochemistry"},{"issue":"16","key":"10.1016\/j.molpha.2026.100114_bib5","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1021\/acs.biochem.8b00337","article-title":"An emerging pathway of doxorubicin cardiotoxicity mediated through CYP2J2","volume":"57","author":"Arnold","year":"2018","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.molpha.2026.100114_bib6","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/cbic.201300646","article-title":"Functional investigations of thromboxane synthase (CYP5A1) in lipid bilayers of nanodiscs","volume":"15","author":"Das","year":"2014","journal-title":"Chembiochem"},{"issue":"8","key":"10.1016\/j.molpha.2026.100114_bib7","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1074\/jbc.M311830200","article-title":"CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids","volume":"279","author":"Chuang","year":"2004","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.molpha.2026.100114_bib8","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00018-016-2443-3","article-title":"Cytochrome P450 2U1, a very peculiar member of the human P450s family","volume":"74","author":"Dhers","year":"2017","journal-title":"Cell Mol Life Sci"},{"issue":"15","key":"10.1016\/j.molpha.2026.100114_bib9","doi-asserted-by":"crossref","first-page":"10476","DOI":"10.1074\/jbc.M114.550004","article-title":"Oxidation of endogenous N-arachidonoylserotonin by human cytochrome P450 2U1","volume":"289","author":"Siller","year":"2014","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.molpha.2026.100114_bib10","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.bbagen.2015.03.014","article-title":"Expression in yeast, new substrates, and construction of a first 3D model of human orphan cytochrome P450 2U1: interpretation of substrate hydroxylation regioselectivity from docking studies","volume":"1850","author":"Ducassou","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"23","key":"10.1016\/j.molpha.2026.100114_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314615","article-title":"Human orphan cytochrome P450 2U1 catalyzes the \u03c9-hydroxylation of leukotriene B4","volume":"23","author":"Nouri","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.molpha.2026.100114_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5501\/wjv.v9.i5.67","article-title":"Thymosin alpha 1: a comprehensive review of the literature","volume":"9","author":"Dominari","year":"2020","journal-title":"World J Virol"},{"key":"10.1016\/j.molpha.2026.100114_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.767785","article-title":"Progress on the function and application of thymosin \u03b24","volume":"12","author":"Xing","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.molpha.2026.100114_bib14","series-title":"Abeloff\u2019s Clinical Oncology","first-page":"1159","article-title":"70 \u2013 Diseases of the pleura and mediastinum","author":"Kaidar-Person","year":"2020"},{"issue":"7","key":"10.1016\/j.molpha.2026.100114_bib15","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3390\/cancers15071953","article-title":"Thymoma and thymic carcinoma: surgical resection and multidisciplinary treatment","volume":"15","author":"Zhang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6352","key":"10.1016\/j.molpha.2026.100114_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.molpha.2026.100114_bib17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/ph3030572","article-title":"Platelet-derived growth factor (PDGF)\/PDGF receptors (PDGFR) axis as target for antitumor and antiangiogenic therapy","volume":"3","author":"Raica","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.molpha.2026.100114_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3892\/ol.2024.14516","article-title":"Expression of vascular endothelial growth factor receptor in thymic epithelial tumors","volume":"28","author":"Chiba","year":"2024","journal-title":"Oncol Lett"},{"issue":"10","key":"10.1016\/j.molpha.2026.100114_bib19","first-page":"4057","article-title":"Expression and mutational status of PDGFR in thymic tumours","volume":"29","author":"Meister","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.molpha.2026.100114_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117118","article-title":"Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: an update","volume":"177","author":"Fan","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.molpha.2026.100114_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1470-2045(14)71181-7","article-title":"Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial","volume":"16","author":"Thomas","year":"2015","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.molpha.2026.100114_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/PPO.0b013e3181af5e35","article-title":"Development of sunitinib in hepatocellular carcinoma: rationale, early clinical experience, and correlative studies","volume":"15","author":"Zhu","year":"2009","journal-title":"Cancer J"},{"issue":"2","key":"10.1016\/j.molpha.2026.100114_bib23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","article-title":"Sorafenib in advanced clear-cell renal-cell carcinoma","volume":"356","author":"Escudier","year":"2007","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.molpha.2026.100114_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1634\/theoncologist.2009-0088","article-title":"Sorafenib and sunitinib","volume":"14","author":"Kim","year":"2009","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.molpha.2026.100114_bib25","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1158\/1078-0432.CCR-08-1893","article-title":"A population pharmacokinetic meta-analysis of sunitinib malate (SU11248) and its primary metabolite (SU12662) in healthy volunteers and oncology patients","volume":"15","author":"Houk","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.molpha.2026.100114_bib26","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/bmc.2697","article-title":"Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study","volume":"26","author":"Rais","year":"2012","journal-title":"Biomed Chromatogr"},{"issue":"2","key":"10.1016\/j.molpha.2026.100114_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jpba.2007.10.027","article-title":"Development of a rapid and sensitive LC-MS\/MS assay for the determination of sorafenib in human plasma","volume":"46","author":"Jain","year":"2008","journal-title":"J Pharm Biomed Anal"},{"issue":"7","key":"10.1016\/j.molpha.2026.100114_bib28","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.clinthera.2007.07.022","article-title":"Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors","volume":"29","author":"Adams","year":"2007","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.molpha.2026.100114_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lungcan.2010.09.011","article-title":"Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation","volume":"71","author":"Di\u015fel","year":"2011","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.molpha.2026.100114_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096664","article-title":"Sorafenib metabolism is significantly altered in the liver tumor tissue of hepatocellular carcinoma patient","volume":"9","author":"Ye","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.molpha.2026.100114_bib31","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1111\/liv.14587","article-title":"Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: implications for combination trials","volume":"40","author":"D\u00edaz-Gonz\u00e1lez","year":"2020","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.molpha.2026.100114_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bcp.2012.04.001","article-title":"Role of human CYP3A4 in the biotransformation of sorafenib to its major oxidized metabolites","volume":"84","author":"Ghassabian","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"10.1016\/j.molpha.2026.100114_bib33","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1021\/acs.chemrestox.8b00005","article-title":"Cytochromes P450 1A2 and 3A4 catalyze the metabolic activation of sunitinib","volume":"31","author":"Amaya","year":"2018","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"10.1016\/j.molpha.2026.100114_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00239-010-9402-7","article-title":"Phylogenetic and functional analysis of the vertebrate cytochrome p450 2 family","volume":"72","author":"Kirischian","year":"2011","journal-title":"J Mol Evol"},{"issue":"2","key":"10.1016\/j.molpha.2026.100114_bib35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3390\/pharmaceutics13020148","article-title":"Assessing the mechanism of fluoxetine-mediated CYP2D6 inhibition","volume":"13","author":"Deodhar","year":"2021","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.molpha.2026.100114_bib36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/17425255.2022.2160317","article-title":"CYP2D6 pharmacogenetics and phenoconversion in personalized medicine","volume":"18","author":"Nahid","year":"2022","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"11","key":"10.1016\/j.molpha.2026.100114_bib37","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2217\/14622416.8.11.1597","article-title":"CYP2D6 polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits","volume":"8","author":"Dorado","year":"2007","journal-title":"Pharmacogenomics"},{"issue":"2","key":"10.1016\/j.molpha.2026.100114_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1074\/mcp.M113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Fagerberg","year":"2014","journal-title":"Mol Cell Proteomics"},{"issue":"6","key":"10.1016\/j.molpha.2026.100114_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nsmb.3195","article-title":"Nanodiscs for structural and functional studies of membrane proteins","volume":"23","author":"Denisov","year":"2016","journal-title":"Nat Struct Mol Biol"},{"issue":"37","key":"10.1016\/j.molpha.2026.100114_bib40","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1021\/acs.biochem.1c00158","article-title":"Differential interactions of selected phytocannabinoids with human CYP2D6 polymorphisms","volume":"60","author":"Huff","year":"2021","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.molpha.2026.100114_bib41","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/acs.jnatprod.3c00336","article-title":"Elucidating the mechanism of metabolism of cannabichromene by human cytochrome P450s","volume":"87","author":"Roy","year":"2024","journal-title":"J Nat Prod"},{"issue":"2","key":"10.1016\/j.molpha.2026.100114_bib42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbrc.2010.06.058","article-title":"Functional reconstitution of monomeric CYP3A4 with multiple cytochrome P450 reductase molecules in nanodiscs","volume":"398","author":"Grinkova","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.molpha.2026.100114_bib43","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/jop.13230","article-title":"Effect of tyrosine kinase inhibitors on cell migration and epithelial-to-mesenchymal transition in Asian head and neck cancer cell lines","volume":"50","author":"Thwe","year":"2021","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"10.1016\/j.molpha.2026.100114_bib44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro","volume":"2","author":"Liang","year":"2007","journal-title":"Nat Protoc"},{"issue":"7","key":"10.1016\/j.molpha.2026.100114_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232565","article-title":"An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays","volume":"15","author":"Suarez-Arnedo","year":"2020","journal-title":"PLoS One"},{"issue":"7873","key":"10.1016\/j.molpha.2026.100114_bib46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.molpha.2026.100114_bib47","doi-asserted-by":"crossref","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","article-title":"AlphaFold protein structure database in 2024: providing structure coverage for over 214 million protein sequences","volume":"52","author":"Varadi","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.molpha.2026.100114_bib48","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","article-title":"PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions","volume":"7","author":"Olsson","year":"2011","journal-title":"J Chem Theory Comput"},{"issue":"7","key":"10.1016\/j.molpha.2026.100114_bib49","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1021\/ct200133y","article-title":"Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values","volume":"7","author":"S\u00f8ndergaard","year":"2011","journal-title":"J Chem Theory Comput"},{"issue":"1","key":"10.1016\/j.molpha.2026.100114_bib50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/pro.4219","article-title":"Spatial arrangement of proteins in planar and curved membranes by PPM 3.0","volume":"31","author":"Lomize","year":"2022","journal-title":"Protein Sci"},{"issue":"11","key":"10.1016\/j.molpha.2026.100114_bib51","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J Comput Chem"},{"issue":"27","key":"10.1016\/j.molpha.2026.100114_bib52","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jcc.23702","article-title":"CHARMM-GUI Membrane Builder toward realistic biological membrane simulations","volume":"35","author":"Wu","year":"2014","journal-title":"J Comput Chem"},{"issue":"8","key":"10.1016\/j.molpha.2026.100114_bib53","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1074\/jbc.M114.627661","article-title":"Contributions of ionic interactions and protein dynamics to cytochrome P450 2D6 (CYP2D6) substrate and inhibitor binding","volume":"290","author":"Wang","year":"2015","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.molpha.2026.100114_bib54","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.bpj.2023.03.018","article-title":"Insights into substrate transport and water permeation in the mycobacterial transporter MmpL3","volume":"122","author":"Li","year":"2023","journal-title":"Biophys J"},{"key":"10.1016\/j.molpha.2026.100114_bib55","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-2105-10-168","article-title":"Fpocket: an open source platform for ligand pocket detection","volume":"10","author":"Le Guilloux","year":"2009","journal-title":"BMC Bioinformatics"},{"issue":"10","key":"10.1016\/j.molpha.2026.100114_bib56","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/jcc.20933","article-title":"The generalized Born\/volume integral implicit solvent model: estimation of the free energy of hydration using London dispersion instead of atomic surface area","volume":"29","author":"Labute","year":"2008","journal-title":"J Comput Chem"},{"issue":"6","key":"10.1016\/j.molpha.2026.100114_bib57","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10822-012-9570-1","article-title":"Variability in docking success rates due to dataset preparation","volume":"26","author":"Corbeil","year":"2012","journal-title":"J Comput Aided Mol Des"},{"issue":"10","key":"10.1016\/j.molpha.2026.100114_bib58","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.3390\/app13106045","article-title":"Impact of cytochrome P450 enzymes on the phase I metabolism of drugs","volume":"13","author":"Iacopetta","year":"2023","journal-title":"Appl Sci"},{"issue":"16","key":"10.1016\/j.molpha.2026.100114_bib59","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"J Comput Chem"},{"issue":"4","key":"10.1016\/j.molpha.2026.100114_bib60","doi-asserted-by":"crossref","DOI":"10.1063\/5.0014475","article-title":"Scalable molecular dynamics on CPU and GPU architectures with NAMD","volume":"153","author":"Phillips","year":"2020","journal-title":"J Chem Phys"},{"issue":"1","key":"10.1016\/j.molpha.2026.100114_bib61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat Methods"},{"issue":"9","key":"10.1016\/j.molpha.2026.100114_bib62","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03d5, \u03c8 and side-chain \u03c7(1) and \u03c7(2) dihedral angles","volume":"8","author":"Best","year":"2012","journal-title":"J Chem Theory Comput"},{"issue":"2","key":"10.1016\/j.molpha.2026.100114_bib63","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J Chem Phys"},{"issue":"4","key":"10.1016\/j.molpha.2026.100114_bib64","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J Comput Chem"},{"issue":"12","key":"10.1016\/j.molpha.2026.100114_bib65","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1021\/ci3003649","article-title":"Automation of the CHARMM General Force Field (CGenFF) II: assignment of bonded parameters and partial atomic charges","volume":"52","author":"Vanommeslaeghe","year":"2012","journal-title":"J Chem Inf Model"},{"issue":"5","key":"10.1016\/j.molpha.2026.100114_bib66","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1063\/1.467468","article-title":"Constant pressure molecular dynamics algorithms","volume":"101","author":"Martyna","year":"1994","journal-title":"J Chem Phys"},{"issue":"11","key":"10.1016\/j.molpha.2026.100114_bib67","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1063\/1.470648","article-title":"Constant pressure molecular dynamics simulation: the langevin piston method","volume":"103","author":"Feller","year":"1995","journal-title":"J Chem Phys"},{"issue":"19","key":"10.1016\/j.molpha.2026.100114_bib68","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J Chem Phys"},{"issue":"23","key":"10.1016\/j.molpha.2026.100114_bib69","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J Computat Phys"},{"issue":"8","key":"10.1016\/j.molpha.2026.100114_bib70","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jcc.540130805","article-title":"Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models","volume":"13","author":"Miyamoto","year":"1992","journal-title":"J Comput Chem"},{"issue":"1","key":"10.1016\/j.molpha.2026.100114_bib71","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graph"},{"issue":"1 Pt A","key":"10.1016\/j.molpha.2026.100114_bib72","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1016\/j.bbagen.2016.07.018","article-title":"Spectral and 3D model studies of the interaction of orphan human cytochrome P450 2U1 with substrates and ligands","volume":"1861","author":"Dhers","year":"2017","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"1","key":"10.1016\/j.molpha.2026.100114_bib73","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.abb.2010.12.008","article-title":"Spectroscopic features of cytochrome P450 reaction intermediates","volume":"507","author":"Luthra","year":"2011","journal-title":"Arch Biochem Biophys"},{"issue":"11","key":"10.1016\/j.molpha.2026.100114_bib74","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1016\/S0021-9258(18)88828-7","article-title":"Heme transfer between phospholipid membranes and uptake by apohemoglobin","volume":"260","author":"Rose","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.molpha.2026.100114_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105416","article-title":"Ligand-binding properties and catalytic activity of the purified human 24-hydroxycholesterol 7\u03b1-hydroxylase, CYP39A1","volume":"193","author":"Grabovec","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.molpha.2026.100114_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.111722","article-title":"Anthracycline derivatives inhibit cardiac CYP2J2","volume":"229","author":"Kim","year":"2022","journal-title":"J Inorg Biochem"},{"issue":"11","key":"10.1016\/j.molpha.2026.100114_bib77","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1021\/acsptsci.5c00463","article-title":"A novel fluorescence polarization binding assay for the main protease (Mpro) of SARS-CoV-2","volume":"8","author":"Wyllie","year":"2025","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"10.1016\/j.molpha.2026.100114_bib78","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/npp.2017.204","article-title":"The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain","volume":"43","author":"Donvito","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.molpha.2026.100114_bib79","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/FTD.0b013e31827efd9e","article-title":"Quantification of sunitinib and N-desethyl sunitinib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry: validation and application in routine therapeutic drug monitoring","volume":"35","author":"Lankheet","year":"2013","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.molpha.2026.100114_bib80","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpba.2018.08.013","article-title":"Analytical aspects of sunitinib and its geometric isomerism towards therapeutic drug monitoring in clinical routine","volume":"160","author":"Posocco","year":"2018","journal-title":"J Pharm Biomed Anal"},{"issue":"6","key":"10.1016\/j.molpha.2026.100114_bib81","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/11318860-000000000-00000","article-title":"Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies","volume":"23","author":"Papaetis","year":"2009","journal-title":"BioDrugs"},{"issue":"10","key":"10.1016\/j.molpha.2026.100114_bib82","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"10.1016\/j.molpha.2026.100114_bib83","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1476-5381.2011.01424.x","article-title":"Epidermal growth factor receptor tyrosine kinase regulates the human inward rectifier potassium K(IR)2.3 channel, stably expressed in HEK 293 cells","volume":"164","author":"Zhang","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.molpha.2026.100114_bib84","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7150\/ijms.1.101","article-title":"Tyrosine kinase \u2013 role and significance in cancer","volume":"1","author":"Paul","year":"2004","journal-title":"Int J Med Sci"},{"issue":"10","key":"10.1016\/j.molpha.2026.100114_bib85","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1021\/ac802612z","article-title":"Screening of type I and II drug binding to human cytochrome P450-3A4 in nanodiscs by localized surface plasmon resonance spectroscopy","volume":"81","author":"Das","year":"2009","journal-title":"Anal Chem"},{"issue":"76","key":"10.1016\/j.molpha.2026.100114_bib86","doi-asserted-by":"crossref","first-page":"11114","DOI":"10.1039\/C4CC05495D","article-title":"Geometric and redox flexibility of pyridine as a redox-active ligand that can reversibly accept one or two electrons","volume":"50","author":"Lewis","year":"2014","journal-title":"Chem Commun (Camb)"},{"issue":"1","key":"10.1016\/j.molpha.2026.100114_bib87","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1021\/ar00097a002","article-title":"Chemical mechanisms of catalysis by cytochromes P-450: a unified view","volume":"17","author":"Guengerich","year":"1984","journal-title":"Acc Chem Res"},{"issue":"11","key":"10.1016\/j.molpha.2026.100114_bib88","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1124\/dmd.108.022376","article-title":"The molecular basis of CYP2D6-mediated N-dealkylation: balance between metabolic clearance routes and enzyme inhibition","volume":"36","author":"Bonn","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.molpha.2026.100114_bib89","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1021\/tx500373g","article-title":"Cytochrome P450-mediated biotransformation of sorafenib and its N-oxide metabolite: implications for cell viability and human toxicity","volume":"28","author":"Gillani","year":"2015","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"10.1016\/j.molpha.2026.100114_bib90","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.lungcan.2014.05.010","article-title":"Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: a tissue micro array-based multicenter study","volume":"85","author":"Lattanzio","year":"2014","journal-title":"Lung Cancer"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X26000143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:25:05Z","timestamp":1790774705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X26000143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0026895X26000143"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100114","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elucidating the binding and metabolic interactions of sunitinib and sorafenib with Cytochrome P450s CYP2U1 and CYP2D6","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2026.100114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100114"}}